ARTICLE | Company News
AstraZeneca, Forest Laboratories deal
August 17, 2009 7:00 AM UTC
Forest granted AstraZeneca exclusive rights to co-develop and commercialize ceftaroline outside the U.S., Canada and Japan. Forest plans to submit an NDA for the cephalosporin antibiotic this year for...